Cargando…

Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D

OBJECTIVE: The objective of this study is to evaluate the effect of Vitamin D3 on symptoms, uterine and leiomyoma volume in women with symptomatic leiomyoma and hypovitaminosis D. MATERIALS AND METHODS: In this pilot, interventional, prospective study, 30 premenopausal women with uterine leiomyoma a...

Descripción completa

Detalles Bibliográficos
Autores principales: Suneja, Amita, Faridi, Fahmina, Bhatt, Shuchi, Guleria, Kiran, Mehndiratta, Mohit, Sharma, Richa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189330/
https://www.ncbi.nlm.nih.gov/pubmed/34188427
http://dx.doi.org/10.4103/jmh.JMH_90_19
_version_ 1783705485426294784
author Suneja, Amita
Faridi, Fahmina
Bhatt, Shuchi
Guleria, Kiran
Mehndiratta, Mohit
Sharma, Richa
author_facet Suneja, Amita
Faridi, Fahmina
Bhatt, Shuchi
Guleria, Kiran
Mehndiratta, Mohit
Sharma, Richa
author_sort Suneja, Amita
collection PubMed
description OBJECTIVE: The objective of this study is to evaluate the effect of Vitamin D3 on symptoms, uterine and leiomyoma volume in women with symptomatic leiomyoma and hypovitaminosis D. MATERIALS AND METHODS: In this pilot, interventional, prospective study, 30 premenopausal women with uterine leiomyoma and concomitant hypovitaminosis D (<30 ng/ml) received Vitamin D3 in doses of 60,000 IU weekly for 8 weeks followed by 60,000 IU every 2 weeks for another 8 weeks. Change in symptoms, uterine, and leiomyoma volume was evaluated at 8 weeks and 16 weeks. Serum Vitamin D3 levels were repeated at 16 weeks of therapy. RESULTS: A significant negative correlation was observed between the baseline 25-hydroxy Vitamin D (25(OH) Vitamin D3) and leiomyoma volume (r = –0.434, P < 0.001). There was significant reduction of menstrual blood loss by 29.89% (P = 0.003) and severity of dysmenorrhea, pelvic pain, and backache by 44.12%, 35%, and 50% (P < 0.001, 0.019, and 0.002), respectively, at 16 weeks. At end of therapy, there was 6% reduction in mean uterine volume and 11% in leiomyoma volume which was not significant. Serum 25(OH) Vitamin D(3) was significantly higher than baseline level (17.44 ± 5.82 vs. 39.38 ± 8.22, P < 0.001) at end of therapy. CONCLUSION: Vitamin D3 supplementation is effective in reducing leiomyoma-related symptoms and stabilizing uterine and leiomyoma volume.
format Online
Article
Text
id pubmed-8189330
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81893302021-06-28 Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D Suneja, Amita Faridi, Fahmina Bhatt, Shuchi Guleria, Kiran Mehndiratta, Mohit Sharma, Richa J Midlife Health Original Article OBJECTIVE: The objective of this study is to evaluate the effect of Vitamin D3 on symptoms, uterine and leiomyoma volume in women with symptomatic leiomyoma and hypovitaminosis D. MATERIALS AND METHODS: In this pilot, interventional, prospective study, 30 premenopausal women with uterine leiomyoma and concomitant hypovitaminosis D (<30 ng/ml) received Vitamin D3 in doses of 60,000 IU weekly for 8 weeks followed by 60,000 IU every 2 weeks for another 8 weeks. Change in symptoms, uterine, and leiomyoma volume was evaluated at 8 weeks and 16 weeks. Serum Vitamin D3 levels were repeated at 16 weeks of therapy. RESULTS: A significant negative correlation was observed between the baseline 25-hydroxy Vitamin D (25(OH) Vitamin D3) and leiomyoma volume (r = –0.434, P < 0.001). There was significant reduction of menstrual blood loss by 29.89% (P = 0.003) and severity of dysmenorrhea, pelvic pain, and backache by 44.12%, 35%, and 50% (P < 0.001, 0.019, and 0.002), respectively, at 16 weeks. At end of therapy, there was 6% reduction in mean uterine volume and 11% in leiomyoma volume which was not significant. Serum 25(OH) Vitamin D(3) was significantly higher than baseline level (17.44 ± 5.82 vs. 39.38 ± 8.22, P < 0.001) at end of therapy. CONCLUSION: Vitamin D3 supplementation is effective in reducing leiomyoma-related symptoms and stabilizing uterine and leiomyoma volume. Wolters Kluwer - Medknow 2021 2021-04-17 /pmc/articles/PMC8189330/ /pubmed/34188427 http://dx.doi.org/10.4103/jmh.JMH_90_19 Text en Copyright: © 2021 Journal of Mid-life Health https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Suneja, Amita
Faridi, Fahmina
Bhatt, Shuchi
Guleria, Kiran
Mehndiratta, Mohit
Sharma, Richa
Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D
title Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D
title_full Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D
title_fullStr Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D
title_full_unstemmed Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D
title_short Effect of Vitamin D3 Supplementation on Symptomatic Uterine Leiomyoma in Women with Hypovitaminosis D
title_sort effect of vitamin d3 supplementation on symptomatic uterine leiomyoma in women with hypovitaminosis d
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189330/
https://www.ncbi.nlm.nih.gov/pubmed/34188427
http://dx.doi.org/10.4103/jmh.JMH_90_19
work_keys_str_mv AT sunejaamita effectofvitamind3supplementationonsymptomaticuterineleiomyomainwomenwithhypovitaminosisd
AT faridifahmina effectofvitamind3supplementationonsymptomaticuterineleiomyomainwomenwithhypovitaminosisd
AT bhattshuchi effectofvitamind3supplementationonsymptomaticuterineleiomyomainwomenwithhypovitaminosisd
AT guleriakiran effectofvitamind3supplementationonsymptomaticuterineleiomyomainwomenwithhypovitaminosisd
AT mehndirattamohit effectofvitamind3supplementationonsymptomaticuterineleiomyomainwomenwithhypovitaminosisd
AT sharmaricha effectofvitamind3supplementationonsymptomaticuterineleiomyomainwomenwithhypovitaminosisd